Testing early supportive care for blood cancers

This trial is testing whether patients with multiple myeloma or aggressive lymphoma benefit from early supportive care — specialized visits focused on managing pain, symptoms, emotions, and life planning — delivered alongside their regular cancer treatment. Half of participants will receive this supportive care from a specialist team, while the other half will receive their usual cancer care. The study measures whether this supportive care approach improves quality of life, reduces symptom burden, and helps patients feel supported during their treatment.

Patients with these aggressive blood cancers often struggle with severe symptoms and emotional distress during treatment, but supportive care is sometimes only offered late in the disease course. This trial tests whether offering this support early — at the time of diagnosis or when disease progresses — can help patients feel better and more in control from the start.